Health
Diabetes drug can treat and reverse heart failure and reduce – EurekAlert
Mount Sinai clinical trial results could help lead to FDA approval
Empagliflozin, a recently developed diabetes drug, can effectively treat and reverse heart failure in both diabetic and non-diabetic patients, according to researchers at the Icahn School of Medicine at Mount Sinai.
Their clinical trial showed that this medication can improve the heart’s size, shape, and function, leading to better exercise capacity and quality of life, which will reduce hospitalizations for heart failure patients. The results were presented on Friday, November 13, at the American…
-
Business14 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business18 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Business10 hours agoDicker Data rides the AI trend to double digit growth
-
General23 hours agoDenmark summons US envoy over suspected influence operations in Greenland